Preparation was coordinated by the American Academy of Ophthalmology Committee on Ophthalmic Procedures Assessment Oculoplastics Surgery Panel: Robert H. Kennedy, MD, PhD; John J. Woog, MD; Philip L. Custer, MD; Sara A. Kaltreider, MD; Dale R. Meyer, MD
Ophthalmology, November 1998, Vol 105, 2154-2159
Reviewed for currency: 2008
The introduction and marketing of lasers for blepharoplasty and skin resurfacing have attracted considerable public interest. For blepharoplasty, the reported advantages of using the CO2 laser include reduced operative time, decreased intraoperative bleeding, and decreased postoperative pain, swelling, and ecchymosis. Final postoperative results, however, have not been shown to differ from those after conventional blepharoplasty. For skin resurfacing, CO2 and Er: YAG lasers offer greater predictability and control of wound depth, decreased risk of scarring and dyspigmentation, and an improved safety profile compared to dermabrasion and chemical peel. Current Er: YAG lasers treat to shallower depth and produce less thermal damage than CO2 lasers. Consequently, the risk of complications may be less after Er: YAG laser treatment, but the desirable effects of tissue shrinkage and improved skin appearance may be reduced slightly as well.
Long-term information about duration of treatment effects, complications, patient satisfaction, and cost-effectiveness is needed to define more clearly the full value of laser skin resurfacing and the appropriate roles for the and CO2 and Er: YAG lasers and to further define the value of laser use for blepharoplasty.